This pooled analysis from five neoadjuvant studies examined the clinical significance of axillary lymph node micrometastases (residual disease) found at surgical axillary intervention after neoadjuvant systemic therapy (NST) in patients with early-stage breast cancer.
The paper metadata provided does not include the full text, so specific outcome data, sample sizes, and detailed findings cannot be extracted or verified.
Explore related topics
